Literature DB >> 29485888

Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts.

Zachary N Warnken1, Hugh D C Smyth1, Daniel A Davis1, Steve Weitman2, John G Kuhn3, Robert O Williams1.   

Abstract

Effective targeting of nasal spray deposition could improve local, systemic, and CNS drug delivery; however, this has proven to be difficult due to the anatomical features of the nasal cavity, including the nasal valve and turbinate structures. Furthermore, nasal cavity geometries and dimensions vary between individuals based on differences in their age, gender, and ethnicity. The effect of patient-specific administration parameters was evaluated for their ability to overcome the barriers of targeted nasal drug delivery. The nasal spray deposition was evaluated in 10 3D-printed nasal cavity replicas developed based on the CT-scans of five pediatric and five adult subjects. Cromolyn sodium nasal solution, USP, modified with varying concentrations of hypromellose was utilized as a model nasal spray to evaluate the deposition pattern from formulations producing a variety of plume angles. A central composite design of experiments was implemented using the formulation with the narrowest plume angle to determine the patient-specific angle for targeting the turbinate region in each individual. The use of the patient-specific angle with this formulation significantly increased the turbinate deposition efficiency compared to that found for all subjects using an administration angle of 30°, around 90% compared to about 73%. Generally, we found turbinate deposition increased with decreases in the administration angle. Deposition to the upper regions of the replica was poor with any formulation or administration angle tested. Effective turbinate targeting of nasal sprays can be accomplished with the use of patient-specific administration parameters in individuals. Further research is required to see if these parameters can be device-controlled for patients and if other regions can be effectively targeted with other nasal devices.

Entities:  

Keywords:  deposition pattern; intranasal administration; nasal drug delivery; nasal spray; personalized medicine; spray angle

Mesh:

Substances:

Year:  2018        PMID: 29485888     DOI: 10.1021/acs.molpharmaceut.7b00702

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  14 in total

Review 1.  Imaging of intranasal drug delivery to the brain.

Authors:  Michael C Veronesi; Mosa Alhamami; Shelby B Miedema; Yeonhee Yun; Miguel Ruiz-Cardozo; Michael W Vannier
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-02-25

2.  Instillation of a Dry Powder in Nasal Casts: Parameters Influencing the Olfactory Deposition With Uni- and Bi-Directional Devices.

Authors:  Clément Rigaut; Laura Deruyver; Jonathan Goole; Benoît Haut; Pierre Lambert
Journal:  Front Med Technol       Date:  2022-06-27

3.  Method for Fabricating Transparent Patient-Specific Vocal Tract Replicas.

Authors:  Michael Rollins; Liran Oren
Journal:  Cleft Palate Craniofac J       Date:  2021-11-10

4.  In Vitro Assessment of Spray Deposition Patterns in a Pediatric (12 Year-Old) Nasal Cavity Model.

Authors:  Namita Sawant; Maureen D Donovan
Journal:  Pharm Res       Date:  2018-03-26       Impact factor: 4.200

5.  Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine.

Authors:  Sachin G Thakkar; Zachary N Warnken; Riyad F Alzhrani; Solange A Valdes; Abdulaziz M Aldayel; Haiyue Xu; Robert O Williams; Zhengrong Cui
Journal:  J Control Release       Date:  2018-10-16       Impact factor: 9.776

6.  In vitro qualitative and quantitative CT assessment of iodinated aerosol nasal deposition using a 3D-printed nasal replica.

Authors:  Thomas Sartoretti; Manoj Mannil; Stefan Biendl; Johannes M Froehlich; Hatem Alkadhi; Matthias Zadory
Journal:  Eur Radiol Exp       Date:  2019-08-21

7.  Non-Invasive Strategies for Nose-to-Brain Drug Delivery.

Authors:  J T Trevino; R C Quispe; F Khan; V Novak
Journal:  J Clin Trials       Date:  2020-12-10

Review 8.  First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines.

Authors:  Marios Charalambous; Holger A Volk; Luc Van Ham; Sofie F M Bhatti
Journal:  BMC Vet Res       Date:  2021-03-04       Impact factor: 2.741

9.  A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies.

Authors:  Laura Nižić Nodilo; Ivo Ugrina; Drago Špoljarić; Daniela Amidžić Klarić; Cvijeta Jakobušić Brala; Mirna Perkušić; Ivan Pepić; Jasmina Lovrić; Vesna Saršon; Maša Safundžić Kučuk; Dijana Zadravec; Livije Kalogjera; Anita Hafner
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.321

10.  Nasal sprayed particle deposition in a human nasal cavity under different inhalation conditions.

Authors:  Hadrien Calmet; Kiao Inthavong; Beatriz Eguzkitza; Oriol Lehmkuhl; Guillaume Houzeaux; Mariano Vázquez
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.